Opus Health: Copay Assistance Programs

August 26, 2016

Author: Kerri Williams/Friday, August 26, 2016/Categories: APCI Choice

 

OPUS Health would like to inform you of the following new Copay Assistance Program(s) (see list below). This new program can be viewed on the OPUS Health Pharmacy Portal. Please use the link below to log in and select View New or Modified Programs to view the new program. If you have already created an account, use the email address and password you created to log in. If you do not have an account, please click on the link below and select Create Account to register. Registering takes just a minute or two and provides access to this and all active programs ? even some printable offers you can provide for your pharmacy customers.

 

New Announcements:

·  Onmel Plan Announcement OH1301011, OH1301021, OH1301031, OH1301041, OH1301051, OH1301061.

·  Naftin Plan Announcement OH1302011, OH1302021, OH1302031, OH1302041, OH1302051, OH1302061.

·  Emverm Copay Plan Announcement OH1402011, OH1402021, OH1402031.

·  Elmiron Copay Plan Announcement OH6403011, OH6403021.

·  Duragesic Plan Announcement OH6402011, OH6402021.

·  Diclegis Copay Plan Announcement OH1901011, OH1901021.

 

http://www.opushealth.com/pharmacyPortal/index.aspx

 

If you are not the correct recipient for Plan Announcements for your organization, you are aware of others who should receive them as well, or you are having difficulty reaching the portal or logging in, please reply to the above address or call us at 1-800-364-4767 and we will be happy to assist you.

 

Thank you,

 

OPUS Health

 

To prevent our plan announcements from being filtered out by your Spam Blocker, please add PlanAnnouncements@OPUSHealth.com to your Email Address Book.

 

This electronic transmission may contain PRIVILEGED AND CONFIDENTIAL information intended only for the addressee(s).  If you are not the intended recipient, or the employee or agent responsible for delivery to the intended recipient(s), please note that any review, dissemination, use, distribution or copying is strictly prohibited.  If you receive this in error, please notify the sender immediately, destroy any paper copies and delete it from any computer.  Thank you.

Comments are only visible to subscribers.